DSS, INC. purchased ~$733K in Impact BioMedical Inc. stock
Impact BioMedical Inc. (IBO) · Data via SEC EDGAR Form 4
Price Performance · 10 days before → 90 days after trade
▲ = insider buy date
Trade Details · Public SEC Filing
Insider
DSS, INC.
Role
—
Transaction
Open-Market Purchase
Approx. Value
~$733K
Trade Date
Sep 18, 2024
Company
Impact BioMedical Inc.
Ticker
IBOSource
SEC EDGAR Form 4
Why This Trade Stands Out
Very Strong conviction signal
Scored in the top tier across multiple factors. Fewer than 5% of insider trades receive this rating.
~$733K purchase
A significant position. Insiders who invest $500K+ of their own money typically have strong views on their company's near-term outlook.
How good is DSS, INC. at picking stocks?
Full track record: win rate, average return, and performance vs S&P 500
On September 18, 2024, DSS, INC. — a corporate insider at Impact BioMedical Inc. — filed a Form 4 with the SEC disclosing an open-market purchase of approximately ~$733K in Impact BioMedical Inc. (IBO) stock.
Under Section 16(a) of the Securities Exchange Act of 1934, corporate insiders must report all open-market stock transactions to the SEC within two business days. These filings — known as Form 4s — are publicly available on the SEC's EDGAR database. VeritySignals filters and scores the full Form 4 stream to surface high-conviction signals like this one.
VeritySignals Conviction Analysis
Full Conviction Analysis
Sign up free to see signal strength details, or upgrade for the full 15-factor breakdown.
Get notified the next time DSS, INC. trades
Free alerts · No credit card · Instant notification
All data sourced from publicly available SEC Form 4 filings via EDGAR · Not financial advice · Past performance does not guarantee future results.
At a Glance
How to Read Insider Trades
What is this?
When company executives buy or sell their own stock, they must report it to the SEC within 2 days. These public filings reveal what the people who know the company best are doing with their own money.
Why does it matter?
Insiders can sell for many reasons (taxes, diversification, expenses), but they generally only buy for one: they think the stock is going up. That's why insider purchases are more predictive than sales.
What makes a trade "strong"?
We score trades on 15+ factors: the insider's role (CEO > director), trade size relative to their salary, whether other insiders also bought (clusters), and historical accuracy of the insider.
Never miss a signal
Get notified when high-conviction insiders buy. Free account, no credit card.
Sign up free